Simultaneous determination of nine acetylcholinesterase inhibitors using micellar electrokinetic chromatography

Journal of Chromatographic Science

Volumn 49, Issue 4, 2011, Pages 265-271

  Nicolaou, Irene N ^a   Kapnissi Christodoulou, Constantina P ^a  

^a UNIVERSITY OF CYPRUS   (Cyprus)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79953225215     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chrsci/49.4.265     Document Type: Article

References (35)

1. S. Gandy. The role of cerebral amyloid beta accumulation in common forms of Alzheimer disease. J. Clin. Invest. 115: 1121-1129 (2005). (Pubitemid 40629026)
2. I. Grundke-Iqbal, K. Iqbal, M. Quinlan, Y.C. Tung, M.S. Zaidi, and H.M. Wisniewski. Microtubule-associated protein tau, a component of Alzheimer paired helical filaments. J. Biol. Chem. 261: 6084-6089 (1986). (Pubitemid 17207447)
3. A.M. Saunders, W.J. Strittmatter, and D. Schmechel. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472 (1993). (Pubitemid 23230526)
4. D.M. Bowen, C.B. Smith, P. White, and A.N. Davison. Neurotransmitter related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99: 459-496 (1976).
5. J.M. Lindstrom, M.E. Seybold, V.A. Lennon, S. Whittingham, and D.D. Duane. Antibody to acetylcholine receptor in myasthenia gravis. Neurology 26: 1054-1059 (1976).
6. B. Zhao, S.M. Moochhala, C.S. Chaw, and Y.Y. Yang. Simple liquid chromatographic method for the determination of physostigmine and its metabolite eseroline in rat plasma: application to a pharmacokinetic study. J. Chromatogr. B 784: 323-329 (2003). (Pubitemid 36044015)
7. R. Whelpton. Analysis of plasma physostigmine concentrations by liquid chromatography. J. Chromatogr. 272: 216-220 (1983). (Pubitemid 13164625)
8. S.M. Somani and A. Khalique. Determination of physostigmine in plasma and brain by HPLC. J. Anal. Toxicol. 9: 71-75 (1985). (Pubitemid 15103607)
9. J.T. Stewart and K.D. Quinn. High performance liquid chromatographic determination of physostigmine and its degradation products in pharmaceutical dosage forms. J. Liq. Chromatogr. 12: 673-683 (1989). (Pubitemid 19148905)
10. J. Havel, J. Patocka, and G. Bocaz. Determination of physostigmine and pyridostigmine in pharmaceutical formulations by capillary electrophoresis. J. Cap. Elec.Microchip Tech. 7: 107-112 (2002)
11. B. Zhao, S.M.Moochhala, and S. Tham. Biologically active components of Physostigma venenosum. J. Chromatogr. B 812: 183-192 (2004). (Pubitemid 39535410)
12. A.W. Abu-Qare and M.B. Abou-Donia. Chromatographic method for the determination of diazepam, pyridostigmine bromide, and their metabolites in rat plasma and urine. J. Chromatogr. B 754: 503-509 (2001). (Pubitemid 32261046)
13. L. Pokorna, A. Revilla, J. Havela, and J. Patocka. Capillary zone electrophoresis determination of galanthamine in biological fluids and pharmaceutical preparatives: Experimental design and artificial neural network optimization. Electrophoresis 20: 1993-1997 (1999). (Pubitemid 29376803)
14. S.V. Frankfort, M. Ouwehand, M.J. Van Maanen, H. Rosing, L.R. Tulner, and J.H. Beijnen. A simple and sensitive assay for the quantitative analysis of rivastigmine and its metabolite NAP 226-90 in human EDTA plasma using coupled liquid chromatography and tandem mass spectrometry. Rapid Commun. Mass Spectrom. 20: 3330-3336 (2006) (Pubitemid 44763929)
15. J. Bhatt, G. Subbaiah, S. Kambli, B. Shah, S. Nigam, M. Patel, A. Saxena, A. Baliga, H. Parekh, and G. Yadav. A rapid and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the estimation of rivastigmine in human plasma. J. Chromatogr. B 852: 115-121 (2007). (Pubitemid 46830101)
16. F. Pommier and R. Frigola. Quantitative determination of rivastigmine and its major metabolite in human plasma by liquid chromatography with atmospheric pressure chemical ionization tandem mass spectrometry. J. Chromatogr. B 784: 301-313 (2003). (Pubitemid 36044013)
17. M. Hossain, S.S. Jhee, T. Shiovitz, C. Mc Donald, G. Sedek, F. Pommier, and N.R. Cutler. Estimation of the absolute bioavailability of rivastigmine in patients withmild tomoderate dementia of the Alzheimer's. Clin. Pharmacokinet. 41: 225-234 (2002). (Pubitemid 34415840)
18. Y. Sha, C.Deng, Z. Liu, T.Huang, B. Yang, andG.Duan.Headspace solid-phase microextraction and capillary gas chromatographicmass spectrometric determination of rivastigmine in canine plasma samples. J. Chromatogr. B 806: 271-276 (2004). (Pubitemid 38686516)
19. A. Kavalirova,M. Pospisilova, and R. Karlicek. Enantiomeric analysis of rivastigmine in pharmaceuticals by cyclodextrin-modified capillary zone electrophoresis. Anal. Chim. Acta 525: 43-51 (2004) (Pubitemid 39330385)
20. S. Terabe. Selectivity manipulation in micellar electrokinetic chromatography. J. Pharm. Biomed. Anal. 10: 705-715 (1992) (Pubitemid 23080421)
21. K.Otsuka and S. Terabe. Effects of pH on electrokinetic velocities in micellar electrokinetic chromatography. J. Microcol. Sep. 1: 150-154 (1989)
22. K.A. Agnew-Heard,M. Sanchez Pena, S.A. Shamsi, and I.M. Studies of polymerized sodium N-undecylenyl-L-valinate in chiral micellar electrokinetic capillary chromatography of neutral, acidic, and basic compounds. Warner. Anal. Chem 69: 958-964 (1997)
23. Z.X. Zheng, J.M. Lin, F. Qu, and T. Hobo. Chiral separation with ligand-exchangemicellar electrokinetic chromatography using a Dpenicillamine- copper(II) ternary complex as chiral selector. Electrophoresis 24: 4221-4226 (2003). (Pubitemid 38094468)
24. D.N. Heiger. High Performance Capillary Electrophoresis-An Introduction, Hewllet-Packard Company, France 2nd ed., 1992, pp. 2-136.
25. P. Hasemann, M. Balk, L. Preu, and H. Watzig. Separation of cold medicine ingredients using a preciseMEKC method at elevated pH. Electrophoresis 28: 1779-1787 (2007). (Pubitemid 46909732)
26. C.W. Henry III, S.A. Shamsi, and I.M.Warner. Separation of natural pyrethrum extracts using micellar electrokinetic chromatography. J. Chromatogr. A 863: 89-103 (1999) (Pubitemid 30046933)
27. B.H. Li, L.P. Yu, and X.P. Yan. An Insight into peak-splitting phenomenon in on-column concentration-micellar electrokinetic capillary chromatography for aqueous sample solution. Anal. Lett. 38: 1975-1985 (2005).
28. C. Rafols, A. Roza, E. Fuguet, M. Roses, and E. Bosch. Solute-solvent interactions in micellar electrokinetic chromatography: V. Factors that produce peak splitting. Electrophoresis 23: 2408-2416 (2002).
29. J. Snopek, I. Jelinek, and E. Smolkova-Keulemansova. Micellar, inclusion and metal-complex enantioselective pseudophases in high-performance electromigration. J. Chromatogr. A 452: 571-590 (1988).
30. J. Gorse, A.T. Balchunas, D.F. Swaile, and M.S. Sepaniak. Effects of organic mobile phase modifiers in micellar electrokinetic capillary chromatography. J. High Resolut. Chromatogr. Chromatogr. Commun. 11: 554-559 (1988).
31. A.T. Balchunas and M.J. Sepaniak. Extension of elution range in micellar electrokinetic capillary chromatography. Anal. Chem. 59: 1466-1470 (1987).
32. S. Ehala, M. Vaher, and M. Kaljurand. Separation of aromatic hydrophobic sulfonates by micellar electrokinetic chromatography. J. Chromatogr. A 1161: 322-326 (2007). (Pubitemid 47088511)
33. R.R. Brodie, L.F. Chasseaud, and A.D. Robbins. Determination of physostigmine in plasma by high-performance liquid chromatography. J. Chromatogr. 415: 423-431 (1987). (Pubitemid 17073973)
34. C.P. Kapnissi, C. Akbay, J.B. Schlenoff, and I.M. Warner. Analytical separations usingmolecularmicelles in open-tubular capillary electrochromatography. Anal. Chem. 74: 2328-2335 (2002). (Pubitemid 34526039)
35. C.P. Kapnissi, B.C. Valle, and I.M. Warner. Chiral separations using polymeric surfactants and polyelectrolyte multilayers in opentubular capillary electrochromatography. Anal. Chem. 75: 6097-6104 (2003). (Pubitemid 37420600)